Skip to main content
. 2014 Jul 28;5:177. doi: 10.3389/fphar.2014.00177

FIGURE 3.

FIGURE 3

Novel targets of antidepressant drugs (ADs). According to the classical view, ADs work by inhibiting neurotransmitter reuptake via transporters of serotonin and norepinephrine. Drug elucidation has revealed that these drugs also bind to EAG K+ channels, lipid-binding proteins, additional transporters, and directly to particular serotonin receptors.